Cargando…
Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
Atopic dermatitis (AD) is among the most common inflammatory skin diseases in children and adults in industrialized countries. Up to one-third of adults (probably a smaller proportion in childhood) suffer from moderate-to-severe AD, whose recommended treatment is usually based on systemic therapies....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439982/ https://www.ncbi.nlm.nih.gov/pubmed/28553077 http://dx.doi.org/10.2147/DDDT.S113192 |